Inflammation and atherosclerosis: Direct versus indirect mechanisms

Current Opinion in Pharmacology

Volumn 13, Issue 2, 2013, Pages 154-160

  Rosenfeld, Michael E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD14 ANTIGEN; CD16 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; CHOLESTEROL; CRYOPYRIN; CYTOKINE; FATTY ACID; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; AIR POLLUTION; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTERY INTIMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CARDIOVASCULAR INFLAMMATION; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL TYPE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DISEASE COURSE; ENDOTHELIAL MICROPARTICLE; ENVIRONMENTAL EXPOSURE; HUMAN; INFLAMMATORY CELL; INNATE IMMUNITY; LEUKOCYTE MICROPARTICLE; LIPID OXIDATION; LIPID STORAGE; LIPOPROTEIN SYNTHESIS; LYMPHOCYTE MICROPARTICLE; MACROPHAGE MICROPARTICLE; MEMBRANE MICROPARTICLE; NATURAL KILLER CELL; NONHUMAN; PERIODONTAL DISEASE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFECTION; REVIEW; SMOKING; STOMACH DISEASE; VIRUS INFECTION;

ANIMALS; ATHEROSCLEROSIS; HUMANS; INFLAMMATION;

EID: 84879411235     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.01.003     Document Type: Review

References (88)

1. G. Siegel An historical perspective on atherosclerosis research in Germany Atherosclerosis 144 1999 1 6
2. F.J. Nieto Infections and atherosclerosis: new clues from an old hypothesis? Am J Epidemiol 148 1998 937 948 (Pubitemid 28533733)
3. G.K. Hansson, P. Libby, U. Schonbeck, and Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291 (Pubitemid 34976993)
4. O. Soehnlein, and C. Weber Myeloid cells in atherosclerosis: initiators and decision shapers Semin Immunopathol 31 2009 35 47
5. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nat Immunol 12 2011 204 212
6. F.K. Swirski, R. Weissleder, and M.J. Pittet Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis Arterioscler Thromb Vasc Biol 29 2009 1424 1432
7. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
8. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
9. I. Tabas, K.J. Williams, and J. Boren Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications Circulation 116 2007 1832 1844 (Pubitemid 350287108)
10. G. Finking, and H. Hanke Nikolaj Nikolajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research Atherosclerosis 135 1997 1 7 (Pubitemid 27469690)
11. D.C. Schwenke, and T.E. Carew Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries Arteriosclerosis 9 1989 908 918 (Pubitemid 20002223)
12. D.C. Schwenke, and T.E. Carew Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions Arteriosclerosis 9 1989 895 907 (Pubitemid 20002222)
13. L. Cominacini, U. Garbin, A.F. Pasini, A. Davoli, M. Campagnola, G.B. Contessi, A.M. Pastorino, and V. Lo Cascio Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells Free Radic Biol Med 22 1997 117 127
14. J. Frostegard, A. Haegerstrand, M. Gidlund, and J. Nilsson Biologically modified LDL increases the adhesive properties of endothelial cells Atherosclerosis 90 1991 119 126
15. M.E. Rosenfeld, W. Palinski, S. Yla-Herttuala, S. Butler, and J.L. Witztum Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits Arteriosclerosis 10 1990 336 349 (Pubitemid 20178662)
16. M.I. Cybulsky, and M.A. Gimbrone Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 251 1991 788 791
17. S. Yla-Herttuala, W. Palinski, M.E. Rosenfeld, S. Parthasarathy, T.E. Carew, S. Butler, J.L. Witztum, and D. Steinberg Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J Clin Invest 84 1989 1086 1095 (Pubitemid 19247577)
18. G.S. Abela Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation J Clin Lipidol 4 2010 156 164
19. S. Freigang, F. Ampenberger, G. Spohn, S. Heer, A.T. Shamshiev, J. Kisielow, M. Hersberger, M. Yamamoto, M.F. Bachmann, and M. Kopf Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis Eur J Immunol 41 2011 2040 2051
20. K.R. Feingold, J.L. Funk, A.H. Moser, J.K. Shigenaga, J.H. Rapp, and C. Grunfeld Role for circulating lipoproteins in protection from endotoxin toxicity Infect Immun 63 1995 2041 2046
21. T. Vaisar, S. Pennathur, P.S. Green, S.A. Gharib, A.N. Hoofnagle, M.C. Cheung, J. Byun, S. Vuletic, S. Kassim, and P. Singh Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL J Clin Invest 117 2007 746 756 (Pubitemid 46348533)
22. T. Vaisar, B. Shao, P.S. Green, M.N. Oda, J.F. Oram, and J.W. Heinecke Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans Curr Atheroscler Rep 9 2007 417 424 (Pubitemid 350104241)
23. A. Undurti, Y. Huang, J.A. Lupica, J.D. Smith, J.A. DiDonato, and S.L. Hazen Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle J Biol Chem 284 2009 30825 30835
24. A. Angelillo-Scherrer Leukocyte-derived microparticles in vascular homeostasis Circ Res 110 2012 356 369
25. L. Burnier, P. Fontana, B.R. Kwak, and A. Angelillo-Scherrer Cell-derived microparticles in haemostasis and vascular medicine Thromb Haemost 101 2009 439 451
26. P.E. Rautou, A.S. Leroyer, B. Ramkhelawon, C. Devue, D. Duflaut, A.C. Vion, G. Nalbone, Y. Castier, G. Leseche, and S. Lehoux Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration Circ Res 108 2011 335 343
27. M.E. Rosenfeld, and L.A. Campbell Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis Thromb Haemost 106 2011 858 867
28. A.J. Curry, I. Portig, J.C. Goodall, P.J. Kirkpatrick, and J.S. Gaston T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens Clin Exp Immunol 121 2000 261 269 (Pubitemid 30659763)
29. M. Mosorin, H.M. Surcel, A. Laurila, M. Lehtinen, R. Karttunen, J. Juvonen, J. Paavonen, R.P. Morrison, P. Saikku, and T. Juvonen Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery Arterioscler Thromb Vasc Biol 20 2000 1061 1067 (Pubitemid 30207583)
30. E. Blessing, L.A. Campbell, M.E. Rosenfeld, and C.C. Kuo Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice Infect Immun 70 2002 5332 5334
31. T.C. Moazed, C.C. Kuo, J.T. Grayston, and L.A. Campbell Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse J Infect Dis 177 1998 1322 1325 (Pubitemid 28194273)
32. E. Blessing, C.C. Kuo, T.M. Lin, L.A. Campbell, F. Bea, B. Chesebro, and M.E. Rosenfeld Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines Circulation 105 2002 1976 1982 (Pubitemid 34437627)
33. Y. Naiki, R. Sorrentino, M.H. Wong, K.S. Michelsen, K. Shimada, S. Chen, A. Yilmaz, A. Slepenkin, N.W. Schroder, and T.R. Crother TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis J Immunol 181 2008 7176 7185
34. L.K. Curtiss, and P.S. Tobias The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis Curr Drug Targets 8 2007 1230 1238
35. K.S. Michelsen, M.H. Wong, P.K. Shah, W. Zhang, J. Yano, T.M. Doherty, S. Akira, T.B. Rajavashisth, and M. Arditi Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis alters plaque phenotype in mice deficient in apolipoprotein E Proc Natl Acad Sci USA 101 2004 10679 10684 (Pubitemid 38955802)
36. P. Tobias, and L.K. Curtiss Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis J Lipid Res 46 2005 404 411 (Pubitemid 43109775)
37. Y. Huang, T. Li, D.C. Sane, and L. Li IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression J Biol Chem 279 2004 51697 51703 (Pubitemid 40017921)
38. F. Geissmann, S. Jung, and D.R. Littman Blood monocytes consist of two principal subsets with distinct migratory properties Immunity 19 2003 71 82 (Pubitemid 36859902)
39. F.K. Swirski, P. Libby, E. Aikawa, P. Alcaide, F.W. Luscinskas, R. Weissleder, and M.J. Pittet Ly-6Chi monocytes dominate hypercholesterolemia- associated monocytosis and give rise to macrophages in atheromata J Clin Invest 117 2007 195 205 (Pubitemid 46048466)
40. F. Tacke, D. Alvarez, T.J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, and N. van Rooijen Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques J Clin Invest 117 2007 185 194 (Pubitemid 46048465)
41. B. Passlick, D. Flieger, and H.W. Ziegler-Heitbrock Identification and characterization of a novel monocyte subpopulation in human peripheral blood Blood 74 1989 2527 2534 (Pubitemid 19286475)
42. E.A. Van Vre, I. Van Brussel, J.M. Bosmans, C.J. Vrints, and H. Bult Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques Mediators Inflamm 2011 2011 941396
43. F.K. Swirski, M. Nahrendorf, M. Etzrodt, M. Wildgruber, V. Cortez-Retamozo, P. Panizzi, J.L. Figueiredo, R.H. Kohler, A. Chudnovskiy, and P. Waterman Identification of splenic reservoir monocytes and their deployment to inflammatory sites Science 325 2009 612 616
44. F.K. Swirski The spatial and developmental relationships in the macrophage family Arterioscler Thromb Vasc Biol 31 2011 1517 1522
45. C.S. Robbins, A. Chudnovskiy, P.J. Rauch, J.L. Figueiredo, Y. Iwamoto, R. Gorbatov, M. Etzrodt, G.F. Weber, T. Ueno, and N. van Rooijen Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions Circulation 125 2012 364 374
46. J. Llodra, V. Angeli, J. Liu, E. Trogan, E.A. Fisher, and G.J. Randolph Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques Proc Natl Acad Sci USA 101 2004 11779 11784 (Pubitemid 39095371)
47. J.E. Feig, J.S. Quick, and E.A. Fisher The role of a murine transplantation model of atherosclerosis regression in drug discovery Curr Opin Investig Drugs 10 2009 232 238
48. R.R. Packard, E. Maganto-Garcia, I. Gotsman, I. Tabas, P. Libby, and A.H. Lichtman CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis Circ Res 103 2008 965 973
49. B.G. Brown, X.Q. Zhao, D.E. Sacco, and J.J. Albers Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease Circulation 87 1993 1781 1791 (Pubitemid 23165620)
50. A.S. Daoud, J. Jarmolych, J.M. Augustyn, and K.E. Fritz Sequential morphologic studies of regression of advanced atherosclerosis Arch Pathol Lab Med 105 1981 233 239 (Pubitemid 11096806)
51. J.E. Feig, S. Parathath, J.X. Rong, S.L. Mick, Y. Vengrenyuk, L. Grauer, M. Dussiot, O. Levillain, S. Graff-Dubois, and A. Nicoletti Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques Circulation 123 2011 989 998
52. J.E. Feig, J.X. Rong, R. Shamir, M. Sanson, Y. Vengrenyuk, J. Liu, K. Rayner, K. Moore, M. Garabedian, and E.A. Fisher HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells Proc Natl Acad Sci USA 108 2011 7166 7171
53. A. Mantovani, C. Garlanda, and M. Locati Macrophage diversity and polarization in atherosclerosis: a question of balance Arterioscler Thromb Vasc Biol 29 2009 1419 1423
54. J.L. Stoger, M.J. Gijbels, S. van der Velden, M. Manca, C.M. van der Loos, E.A. Biessen, M.J. Daemen, E. Lutgens, and M.P. de Winther Distribution of macrophage polarization markers in human atherosclerosis Atherosclerosis 225 2012 461 468
55. J. Khallou-Laschet, A. Varthaman, G. Fornasa, C. Compain, A.T. Gaston, M. Clement, M. Dussiot, O. Levillain, S. Graff-Dubois, and A. Nicoletti Macrophage plasticity in experimental atherosclerosis PLoS ONE 5 2010 e8852
56. J. Andersson, P. Libby, and G.K. Hansson Adaptive immunity and atherosclerosis Clin Immunol 134 2010 33 46
57. C.M. Ausiello, G. Fedele, R. Palazzo, F. Spensieri, A. Ciervo, and A. Cassone 60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells Microbes Infect 8 2006 714 720
58. S. Adamson, and N. Leitinger Phenotypic modulation of macrophages in response to plaque lipids Curr Opin Lipidol 22 2011 335 342
59. A. Kadl, A.K. Meher, P.R. Sharma, M.Y. Lee, A.C. Doran, S.R. Johnstone, M.R. Elliott, F. Gruber, J. Han, and W. Chen Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2 Circ Res 107 2010 737 746
60. R.N. Hanna, I. Shaked, H.G. Hubbeling, J.A. Punt, R. Wu, E. Herrley, C. Zaugg, H. Pei, F. Geissmann, and K. Ley NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis Circ Res 110 2012 416 427
61. K. El Hadri, D.F. Mahmood, D. Couchie, I. Jguirim-Souissi, F. Genze, V. Diderot, T. Syrovets, O. Lunov, T. Simmet, and M. Rouis Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis Arterioscler Thromb Vasc Biol 32 2012 1445 1452
62. D. Shiraishi, Y. Fujiwara, Y. Komohara, H. Mizuta, and M. Takeya Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation Biochem Biophys Res Commun 425 2012 304 308
63. X. Cheng, E.J. Folco, K. Shimizu, and P. Libby Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cells J Biol Chem 287 2012 36896 36904
64. S. Devaraj, and I. Jialal C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype Arterioscler Thromb Vasc Biol 31 2011 1397 1402
65. E. Maganto-Garcia, M.L. Tarrio, N. Grabie, D.X. Bu, and A.H. Lichtman Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia Circulation 124 2011 185 195
66. I. Gotsman, N. Grabie, R. Gupta, R. Dacosta, M. MacConmara, J. Lederer, G. Sukhova, J.L. Witztum, A.H. Sharpe, and A.H. Lichtman Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule Circulation 114 2006 2047 2055 (Pubitemid 44706881)
67. B.H. Hahn, J. Grossman, W. Chen, and M. McMahon The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia J Autoimmun 28 2007 69 75 (Pubitemid 46670686)
68. J.L. Mehta, T.G. Saldeen, and K. Rand Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease J Am Coll Cardiol 31 1998 1217 1225 (Pubitemid 28219109)
69. R.D. Brook, S. Rajagopalan, C.A. Pope III, J.R. Brook, A. Bhatnagar, A.V. Diez-Roux, F. Holguin, Y. Hong, R.V. Luepker, and M.A. Mittleman Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association Circulation 121 2010 2331 2378
70. L.A. Campbell, K. Yaraei, B. Van Lenten, A. Chait, E. Blessing, C.C. Kuo, T. Nosaka, J. Ricks, and M.E. Rosenfeld The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis Microbes Infect 12 2010 598 606
71. M. Sakai, K. Yamashita, N. Takemoto, Y. Ohshima, M. Tsukimoto, Y. Shinkai, K. Takeda, S. Oshio, and S. Kojima Diesel exhaust (DE) aggravates pathology of delayed-type hypersensitivity (DTH) induced by methyl-bovine serum albumin (mBSA) in mice J Toxicol Sci 34 2009 483 492
72. K. Hiramatsu, A. Azuma, S. Kudoh, M. Desaki, H. Takizawa, and I. Sugawara Inhalation of diesel exhaust for three months affects major cytokine expression and induces bronchus-associated lymphoid tissue formation in murine lungs Exp Lung Res 29 2003 607 622 (Pubitemid 37463931)
73. H. Takano, T. Yoshikawa, T. Ichinose, Y. Miyabara, K. Imaoka, and M. Sagai Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice Am J Respir Crit Care Med 156 1997 36 42 (Pubitemid 27293164)
74. J.A. Deiuliis, T. Kampfrath, J. Zhong, S. Oghumu, A. Maiseyeu, L.C. Chen, Q. Sun, A.R. Satoskar, and S. Rajagopalan Pulmonary T cell activation in response to chronic particulate air pollution Am J Physiol Lung Cell Mol Physiol 302 2012 L399 L409
75. F. Tavora, R. Kutys, L. Li, M. Ripple, D. Fowler, and A. Burke Adventitial lymphocytic inflammation in human coronary arteries with intimal atherosclerosis Cardiovasc Pathol 19 2010 e61 e68
76. C.N. Lumeng, and A.R. Saltiel Inflammatory links between obesity and metabolic disease J Clin Invest 121 2011 2111 2117
77. E.A. Fisher, J.E. Feig, B. Hewing, S.L. Hazen, and J.D. Smith High-density lipoprotein function, dysfunction, and reverse cholesterol transport Arterioscler Thromb Vasc Biol 32 2012 2813 2820
78. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med 62 1977 707 714 (Pubitemid 8110784)
79. J.W. Heinecke The protein cargo of HDL: implications for vascular wall biology and therapeutics J Clin Lipidol 4 2010 371 375
80. W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, and A. Kontush Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler Thromb Vasc Biol 29 2009 870 876
81. U. Landmesser High density lipoprotein - should we raise it? Curr Vasc Pharmacol 10 2012 718 719
82. B.J. Van Lenten, A.C. Wagner, D.P. Nayak, S. Hama, M. Navab, and A.M. Fogelman High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection Circulation 103 2001 2283 2288 (Pubitemid 32433719)
83. J.A. Araujo, B. Barajas, M. Kleinman, X. Wang, B.J. Bennett, K.W. Gong, M. Navab, J. Harkema, C. Sioutas, and A.J. Lusis Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress Circ Res 102 2008 589 596 (Pubitemid 351416760)
84. M.Y. Chou, L. Fogelstrand, K. Hartvigsen, L.F. Hansen, D. Woelkers, P.X. Shaw, J. Choi, T. Perkmann, F. Backhed, and Y.I. Miller Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans J Clin Invest 119 2009 1335 1349
85. K. Hartvigsen, M.Y. Chou, L.F. Hansen, P.X. Shaw, S. Tsimikas, C.J. Binder, and J.L. Witztum The role of innate immunity in atherogenesis J Lipid Res 50 Suppl 2009 S388 S393
86. C. Hwee Ming, and S. Kalyana Cholesterol oxides and natural autoantibodies Atherosclerosis 141 1998 347 348 (Pubitemid 28539642)
87. A. Horvath, and A. Biro Anti-cholesterol antibodies in human sera Autoimmun Rev 2 2003 272 277 (Pubitemid 37083494)
88. B. Metzler, Q. Xu, and G. Wick The role of (auto-) immunity in atherogenesis Wien Klin Wochenschr 110 1998 350 355 (Pubitemid 28257422)